Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Cipla Limited
  6. Summary
    CIPLA   INE059A01026

CIPLA LIMITED

(CIPLA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
11/30/2021 12/01/2021 12/02/2021 12/03/2021 12/06/2021 Date
971.3(c) 928.15(c) 921.25(c) 912.05(c) 894.95 Last
4 771 579 3 879 683 2 749 084 2 388 529 1 573 419 Volume
+0.65% -4.44% -0.74% -1.00% -1.87% Change
More quotes
Estimated financial data (e)
Sales 2022 215 B 2 854 M 2 854 M
Net income 2022 27 902 M 370 M 370 M
Net cash position 2022 24 768 M 329 M 329 M
P/E ratio 2022 25,8x
Yield 2022 0,57%
Sales 2023 233 B 3 097 M 3 097 M
Net income 2023 33 222 M 441 M 441 M
Net cash position 2023 49 313 M 654 M 654 M
P/E ratio 2023 21,7x
Yield 2023 0,63%
Capitalization 722 B 9 595 M 9 581 M
EV / Sales 2022 3,24x
EV / Sales 2023 2,88x
Nbr of Employees 25 672
Free-Float 62,0%
More Financials
Company
Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled... 
Sector
Pharmaceuticals
Calendar
02/09Earnings Release
More about the company
Ratings of Cipla Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CIPLA LIMITED
12/03Indian shares surrender early gains on Omicron worries
RE
12/02Indian Indices Close Higher for Second Straight Day on Thursday; Adani Ports Jumps 4%
MT
12/01Indian Indices Settle in Green Midweek; IndusInd Bank Soars 6%
MT
11/26Indian Indices End Lower on Friday; JSW Steel Plunges 8%
MT
11/26Indian shares drop most in 7 months on fears over new virus variant
RE
11/26Indian shares slide on virus variant fears, set for big weekly losses
RE
11/26Indian shares drop over 2% as new virus variant spooks investors
RE
11/26CIPLA : Disclosure of related party transactions for the half year ended 30th September 20..
PU
11/18Cipla launches Spirofy - Strengthens its lung leadership position by facilitating early..
AQ
11/17CIPLA LAUNCHES SPIROFY« : Strengthens its lung leadership position by facilitating early d..
PU
11/17Cipla Launches Portable Wireless Spirometer
MT
11/16Cipla Limited Announces the Launch of Spirofy
CI
11/15CIPLA : ranked as one of the most sustainable healthcare companies in the Dow Jones Sustai..
PU
11/15Indian Indices Close Marginally Higher on Monday; Power Grid Corporation of India
MT
10/29Earnings Call Transcript Q2FY22
PU
More news
News in other languages on CIPLA LIMITED
12/03Les actions indiennes abandonnent leurs gains initiaux en raison des inquiétudes liées ..
12/02Les indices indiens clôturent en hausse pour la deuxième journée consécutive jeudi ; Ad..
12/01Les indices indiens s'installent dans le vert en milieu de semaine ; l'IndusInd Bank gr..
11/26Les indices indiens terminent en baisse vendredi ; JSW Steel plonge de 8%.
11/26Les actions indiennes connaissent leur plus forte baisse depuis sept mois en raison des..
More news
Analyst Recommendations on CIPLA LIMITED
More recommendations
Chart CIPLA LIMITED
Duration : Period :
Cipla Limited Technical Analysis Chart | CIPLA | INE059A01026 | MarketScreener
Technical analysis trends CIPLA LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 35
Last Close Price 894,95 INR
Average target price 1 057,43 INR
Spread / Average Target 18,2%
EPS Revisions
Managers and Directors
Umang Vohra Global Chief Executive Officer, MD & Director
Raju Mistry President & Global Chief People Officer
Kedar Upadhye Global Chief Financial Officer
Yusuf Khwaja Hamied Non-Executive Chairman
Jaideep A. Gogtay Global Chief Medical Officer